Mosaic Biomedicals
Mosaic Biomedicals was a Catalan biotechnology company developing humanised antibodies for the use in oncology.
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|
| Revenues | <1m | 1.8m | 7.0m | 10.2m |
| % growth | - | 199561 % | 281 % | 45 % |
| EBITDA | (<1m) | 1.3m | 6.8m | 9.3m |
| % EBITDA margin | (30886 %) | 68 % | 97 % | 91 % |
| Profit | (<1m) | <1m | 1.9m | 1.2m |
| % profit margin | (44904 %) | 30 % | 27 % | 12 % |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
N/A | Spinout | ||
| N/A | N/A | Acquisition | |
| Total Funding | - | ||
Related Content
Recent News about Mosaic Biomedicals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.